Alector, Inc. (ALEC) income statement
ALECNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$2.57+0.01 (+0.39%)
Close on Nov 18, 2026Market cap $286.96MP/E –Yield –
Alector, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- -912.4%
- Net margin
- -850.1%
- Return on equity, FY2025
- -181.6%
Financial strength
- Current ratio
- 5.26
- Debt to equity
- -0.99
- Debt to assets
- 4.9%
- Cash to current liabilities
- 175.0%
Valuation
- P/E ratio
- –
- Price to sales
- 20.70
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?